Viewing Study NCT02919059


Ignite Creation Date: 2025-12-24 @ 2:24 PM
Ignite Modification Date: 2026-02-28 @ 3:48 AM
Study NCT ID: NCT02919059
Status: UNKNOWN
Last Update Posted: 2017-03-29
First Post: 2016-09-23
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: Study to Asses the Effect of Dapagliflozin on Central Blood Pressure Reduction.
Sponsor: IInstituto Gallego de Medicina Vascular
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Diabetes Mellitus, Type 2 View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Diabetes Mellitus, Type 2 View
None DM View